Stroke Risk Factors of Stroke Patients in China: A Nationwide Community-Based Cross-Sectional Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Participants
2.2. Data Collection and Definition
- The confidence level was 95% (bilateral), corresponding u = 1.96;
- Probability p was 9.7% of monitored diabetes prevalence in 2010;
- deff value of design efficiency was set as 3;
- Relative error r = 20%, d = 20% × 9.7%.
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Feigin, V.L.; Forouzanfar, M.H.; Krishnamurthi, R.; Mensah, G.A.; Connor, M.; Bennett, D.A.; Moran, A.E.; Sacco, R.L.; Anderson, L.; Truelsen, T.; et al. Global and regional burden of stroke during 1990–2010: Findings from the Global Burden of Disease Study 2010. Lancet 2014, 383, 245–254. [Google Scholar] [CrossRef]
- Liu, L.; Wang, D.; Wong, K.S.; Wang, Y. Stroke and stroke care in China: Huge burden, significant workload, and a national priority. Stroke 2011, 42, 3651–3654. [Google Scholar] [CrossRef] [PubMed]
- Progress Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358, 1033–1041. [Google Scholar] [CrossRef]
- Sacco, R.L.; Diener, H.C.; Yusuf, S.; Cotton, D.; Ounpuu, S.; Lawton, W.A.; Palesch, Y.; Martin, R.H.; Albers, G.W.; Bath, P.; et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N. Engl. J. Med. 2008, 359, 1238–1251. [Google Scholar] [CrossRef] [PubMed]
- Amarenco, P.; Bogousslavsky, J.; Callahan, A.R.; Goldstein, L.B.; Hennerici, M.; Rudolph, A.E.; Sillesen, H.; Simunovic, L.; Szarek, M.; Welch, K.M.; et al. High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med. 2006, 355, 549–559. [Google Scholar] [CrossRef]
- Bhatt, D.L.; Steg, P.G.; Ohman, E.M.; Hirsch, A.T.; Ikeda, Y.; Mas, J.L.; Goto, S.; Liau, C.S.; Richard, A.J.; Röther, J.; et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006, 295, 180–189. [Google Scholar] [CrossRef] [Green Version]
- Tseng, C.H.; Chong, C.K.; Sheu, J.J.; Wu, T.H.; Tseng, C.P. Prevalence and risk factors for stroke in Type 2 diabetic patients in Taiwan: A cross-sectional survey of a national sample by telephone interview. Diabet. Med. 2005, 22, 477–482. [Google Scholar] [CrossRef]
- Marrugat, J.; Arboix, A.; García-Eroles, L.; Salas, T.; Vila, J.; Castell, C.; Tresserras, R.; Elosua, R. The estimated incidence and case fatality rate of ischemic and hemorrhagic cerebrovascular disease in 2002 in Catalonia. Rev. Esp. Cardiol. 2007, 60, 573–580. [Google Scholar] [CrossRef]
- Quinn, T.J.; Paolucci, S.; Sunnerhagen, K.S.; Sivenius, J.; Walker, M.F.; Toni, D.; Lees, K.R. Evidence-based stroke r-ehabilitation: An expanded guidance document from the european stroke organisation (ESO) guidelines for management of ischaemic stroke and transient ischaemic attack 2008. J. Rehabil. Med. 2009, 41, 99–111. [Google Scholar] [CrossRef] [Green Version]
- Arboix, A. Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J. Clin. Cases 2015, 3, 418–429. [Google Scholar] [CrossRef]
- Kernan, W.N.; Ovbiagele, B.; Black, H.R.; Bravata, D.M.; Chimowitz, M.I.; Ezekowitz, M.D.; Fang, M.C.; Fisher, M.; Furie, K.L.; Heck, D.V.; et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014, 45, 2160–2236. [Google Scholar] [CrossRef] [PubMed]
- Jiang, Y.; Yang, X.; Li, Z.; Pan, Y.; Wang, Y.; Wang, Y.; Ji, R.; Wang, C. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China. Neurol. Res. 2017, 39, 492–497. [Google Scholar] [CrossRef] [PubMed]
- Li, Z.; Wang, C.; Zhao, X.; Liu, L.; Wang, C.; Li, H.; Shen, H.; Liang, L.; Bettger, J.; Yang, Q.; et al. Substantial Progress Yet Significant Opportunity for Improvement in Stroke Care in China. Stroke 2016, 47, 2843–2849. [Google Scholar] [CrossRef] [PubMed]
- Beaney, T.; Burrell, L.M.; Castillo, R.R.; Charchar, F.J.; Cro, S.; Damasceno, A.; Kruger, R.; Nilsson, P.M.; Prabhakaran, D.; Ramirez, A.J.; et al. May Measurement Month 2018: A pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. Eur. Heart J. 2019, 40, 2006–2017. [Google Scholar] [CrossRef] [Green Version]
- Chia, Y.C.; Ching, S.M.; Chew, B.N.; Devaraj, N.K.; Siti Suhaila, M.Y.; Tay, C.L.; Kang, P.S.; Verna Lee, K.M.; Kong, S.Z.; Teoh, S.W.; et al. May Measurement Month 2017 blood pressure screening: Findings from Malaysia-South-East Asia and Australasia. Eur. Heart J. Suppl. 2019, 21, D77–D79. [Google Scholar] [CrossRef]
- Shen, S.; Li, X.; Yuan, C.; Huang, Q.; Liu, D.; Ma, S.; Hui, J.; Liu, R.; Wu, T.; Chen, Q. Association of short-term exposure to sulfur dioxide and hospitalization for ischemic and hemorrhagic stroke in Guangzhou, China. BMC Public Health 2020, 20, 263. [Google Scholar] [CrossRef] [Green Version]
- Wolf-Maier, K.; Cooper, R.S.; Banegas, J.R.; Giampaoli, S.; Hense, H.W.; Joffres, M.; Kastarinen, M.; Poulter, N.; Primatesta, P.; Rodríguez-Artalejo, F.; et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289, 2363–2369. [Google Scholar] [CrossRef] [Green Version]
- Yan, X.; Liu, Z.; Guo, Z.N.; Sun, Y.; Jin, H.; Sun, X.; Sun, H.; Yang, Y. Positive Influence of Stroke Health Manager on Risk Factors Control and Medication Adherence After Ischemic Stroke. Front. Neurol. 2020, 11, 168. [Google Scholar] [CrossRef] [Green Version]
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106, 3143–3421. [CrossRef]
- Baigent, C.; Blackwell, L.; Emberson, J.; Holland, L.E.; Reith, C.; Bhala, N.; Peto, R.; Barnes, E.H.; Keech, A.; Simes, J.; et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010, 376, 1670–1681. [Google Scholar] [CrossRef] [Green Version]
- Liu, Z.; Lin, W.; Lu, Q.; Wang, J.; Liu, P.; Lin, X.; Wang, F.; Shi, Y.; Wang, Q.; Liu, G.; et al. Risk factors affecting the 1-year outcomes of minor ischemic stroke: Results from Xi’an stroke registry study of China. BMC Neurol. 2020, 20, 379. [Google Scholar] [CrossRef] [PubMed]
- Yu, D.; Zhao, L.; Zhang, J.; Yang, Z.; Yang, L.; Huang, J.; Fang, H.; Guo, Q.; Xu, X.; Ju, L.; et al. China Nutrition and Health Surveys (1982–2017). China CDC Wkly. 2021, 3, 193–195. [Google Scholar] [CrossRef] [PubMed]
- Goulart, A.C.; Fernandes, T.G.; Santos, I.S.; Alencar, A.P.; Bensenor, I.M.; Lotufo, P.A. Predictors of long-term survival among first-ever ischemic and hemorrhagic stroke in a Brazilian stroke cohort. BMC Neurol. 2013, 13, 51. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Habibi-Koolaee, M.; Shahmoradi, L.; Niakan Kalhori, S.R.; Ghannadan, H.; Younesi, E. Prevalence of Stroke Risk Factors and Their Distribution Based on Stroke Subtypes in Gorgan: A Retrospective Hospital-Based Study-2015–2016. Neurol. Res. Int. 2018, 2018, 2709654. [Google Scholar] [CrossRef]
- Grau, A.J.; Weimar, C.; Buggle, F.; Heinrich, A.; Goertler, M.; Neumaier, S.; Glahn, J.; Brandt, T.; Hacke, W.; Diener, H.C. Risk factors, outcome, and treatment in subtypes of ischemic stroke: The German stroke data bank. Stroke 2001, 32, 2559–2566. [Google Scholar] [CrossRef] [PubMed]
- Kimura, K.; Kazui, S.; Minematsu, K.; Yamaguchi, T. Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan. A hospital-based prospective registration study. Cerebrovasc. Dis. 2004, 18, 47–56. [Google Scholar] [CrossRef]
- Kim, B.J.; Park, J.M.; Kang, K.; Lee, S.J.; Ko, Y.; Kim, J.G.; Cha, J.K.; Kim, D.H.; Nah, H.W.; Han, M.K.; et al. Case characteristics, hyperacute treatment, and outcome information from the clinical research center for stroke-fifth division registry in South Korea. J. Stroke 2015, 17, 38–53. [Google Scholar] [CrossRef] [Green Version]
- Hong, K.S. Blood Pressure Management for Stroke Prevention and in Acute Stroke. J. Stroke 2017, 19, 152–165. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Xu, J.; Zhao, X.; Wang, D.; Wang, C.; Liu, L.; Wang, A.; Meng, X.; Li, H.; Wang, Y. Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke 2013, 44, 1232–1237. [Google Scholar] [CrossRef] [PubMed]
- Ovbiagele, B.; Diener, H.C.; Yusuf, S.; Martin, R.H.; Cotton, D.; Vinisko, R.; Donnan, G.A.; Bath, P.M. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA 2011, 306, 2137–2144. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Towfighi, A.; Markovic, D.; Ovbiagele, B. Consistency of blood pressure control after ischemic stroke: Prevalence and prognosis. Stroke 2014, 45, 1313–1317. [Google Scholar] [CrossRef] [Green Version]
- Ma, S.; Yang, L.; Zhao, M.; Magnussen, C.G.; Xi, B. Trends in hypertension prevalence, awareness, treatment and control rates among Chinese adults, 1991–2015. J. Hypertens. 2021, 39, 740–748. [Google Scholar] [CrossRef] [PubMed]
- Xu, Y.; Wang, L.; He, J.; Bi, Y.; Li, M.; Wang, T.; Wang, L.; Jiang, Y.; Dai, M.; Lu, J.; et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013, 310, 948–959. [Google Scholar] [CrossRef] [PubMed]
- Kannel, W.B.; McGee, D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241, 2035–2038. [Google Scholar] [CrossRef] [PubMed]
- Abbott, R.D.; Donahue, R.P.; MacMahon, S.W.; Reed, D.M.; Yano, K. Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 1987, 257, 949–952. [Google Scholar] [CrossRef] [PubMed]
- Davis, P.H.; Dambrosia, J.M.; Schoenberg, B.S.; Schoenberg, D.G.; Pritchard, D.A.; Lilienfeld, A.M.; Whisnant, J.P. Risk factors for ischemic stroke: A prospective study in Rochester, Minnesota. Ann. Neurol. 1987, 22, 319–327. [Google Scholar] [CrossRef] [PubMed]
- Mankovsky, B.N.; Ziegler, D. Stroke in patients with diabetes mellitus. Diabetes Metab. Res. Rev. 2004, 20, 268–287. [Google Scholar] [CrossRef] [PubMed]
- Sarwar, N.; Gao, P.; Seshasai, S.R.; Gobin, R.; Kaptoge, S.; Di Angelantonio, E.; Ingelsson, E.; Lawlor, D.A.; Selvin, E.; Stampfer, M.; et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375, 2215–2222. [Google Scholar] [CrossRef] [Green Version]
- Teoh, R.J.J.; Huang, C.J.; Chan, C.P.; Chien, L.Y.; Chung, C.P.; Sung, S.H.; Chen, C.H.; Chiang, C.E.; Cheng, H.M. Does statin increase the risk of intracerebral hemorrhage in stroke survivors? A meta-analysis and trial sequential analysis. Ther. Adv. Neurol. Disord. 2019, 12, 1278086398. [Google Scholar] [CrossRef] [Green Version]
- Ansell, B.J. Cholesterol, stroke risk, and stroke prevention. Curr. Atheroscler. Rep. 2000, 2, 92–96. [Google Scholar] [CrossRef]
- Han, J.; Choi, Y.K.; Leung, W.K.; Hui, M.T.; Leung, M.K.W. Long term clinical outcomes of patients with ischemic stroke in primary care—A 9-year retrospective study. BMC Fam. Pract. 2021, 22, 164. [Google Scholar] [CrossRef]
- Kang, Y.N.; Shen, H.N.; Lin, C.Y.; Elwyn, G.; Huang, S.C.; Wu, T.F.; Hou, W.H. Does a Mobile app improve patients’ knowledge of stroke risk factors and health-related quality of life in patients with stroke? A randomized controlled trial. BMC Med. Inform. Decis. Mak. 2019, 19, 282. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Li, Z.; Zhao, X.; Wang, C.; Wang, X.; Wang, D.; Liang, L.; Liu, L.; Wang, C.; Li, H.; et al. Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients With Acute Ischemic Stroke in China: A Randomized Clinical Trial. JAMA 2018, 320, 245–254. [Google Scholar] [CrossRef]
- Belfiore, P.; Miele, A.; Gallè, F.; Liguori, G. Adapted physical activity and stroke: A systematic review. J. Sports Med. Phys. Fitness 2018, 58, 1867–1875. [Google Scholar] [CrossRef] [PubMed]
- Howard, A.A.; Arnsten, J.H.; Gourevitch, M.N. Effect of alcohol consumption on diabetes mellitus: A systematic review. Ann. Intern. Med. 2004, 140, 211–219. [Google Scholar] [CrossRef]
- Koppes, L.L.; Dekker, J.M.; Hendriks, H.F.; Bouter, L.M.; Heine, R.J. Moderate alcohol consumption lowers the risk of type 2 diabetes: A meta-analysis of prospective observational studies. Diabetes Care 2005, 28, 719–725. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Krenz, M.; Korthuis, R.J. Moderate ethanol ingestion and cardiovascular protection: From epidemiologic associations to cellular mechanisms. J. Mol. Cell Cardiol. 2012, 52, 93–104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Krishnan, E.; Pandya, B.J.; Chung, L.; Hariri, A.; Dabbous, O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: A 15-year follow-up study. Am. J. Epidemiol. 2012, 176, 108–116. [Google Scholar] [CrossRef] [Green Version]
- Ndrepepa, G. Uric acid and cardiovascular disease. Clin. Chim. Acta 2018, 484, 150–163. [Google Scholar] [CrossRef] [PubMed]
- Peng, T.C.; Wang, C.C.; Kao, T.W.; Chan, J.Y.; Yang, Y.H.; Chang, Y.W.; Chen, W.L. Relationship between hyperuricemia and lipid profiles in US adults. Biomed. Res. Int. 2015, 2015, 127596. [Google Scholar] [CrossRef] [PubMed]
- Schwingshackl, L.; Schwedhelm, C.; Hoffmann, G.; Knüppel, S.; Iqbal, K.; Andriolo, V.; Bechthold, A.; Schlesinger, S.; Boeing, H. Food Groups and Risk of Hypertension: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies. Adv. Nutr. 2017, 8, 793–803. [Google Scholar] [CrossRef] [PubMed]
- Tong, X.; Dong, J.Y.; Wu, Z.W.; Li, W.; Qin, L.Q. Dairy consumption and risk of type 2 diabetes mellitus: A meta-analysis of cohort studies. Eur. J. Clin. Nutr. 2011, 65, 1027–1031. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Trigo, J.P.; Alexandre, E.M.C.; Saraiva, J.A.; Pintado, M.E. High value-added compounds from fruit and vegetable by-products—Characterization, bioactivities, and application in the development of novel food products. Crit. Rev. Food Sci. Nutr. 2020, 60, 1388–1416. [Google Scholar] [CrossRef] [PubMed]
- Owolabi, M.O.; Thrift, A.G.; Martins, S.; Johnson, W.; Pandian, J.; Abd-Allah, F.; Varghese, C.; Mahal, A.; Yaria, J.; Phan, H.T.; et al. The state of stroke services across the globe: Report of World Stroke Organization-World Health Organization surveys. Int. J. Stroke 2021, 16, 889–901. [Google Scholar] [CrossRef] [PubMed]
Characteristics | Proportion | χ2 | p | |
---|---|---|---|---|
Gender | 31.879 | <0.001 | ||
Male | 53.48 | |||
Female | 46.52 | |||
Residence | 47.320 | 0.071 | ||
Urban | 45.76 | |||
Rural | 54.24 | |||
Ethnicity | 16,160.849 | <0.001 | ||
Han | 92.80 | |||
Zhuang | 0.46 | |||
Manchu | 1.64 | |||
Others | 5.11 | |||
Age group | 4852.297 | <0.001 | ||
18–39 | 0.1 | |||
40–59 | 0.7 | |||
≥60 | 4.8 | |||
Education | 4690.508 | <0.001 | ||
Primary school or lower | 58.48 | |||
Junior middle school | 26.91 | |||
Senior middle school | 11.25 | |||
College and above | 3.36 | |||
Marital status | 14,719.590 | <0.001 | ||
Never married | 0.70 | |||
Married/partner | 89.51 | |||
Divorced or separated | 0.93 | |||
Widowed | 8.86 | |||
Region | 220.155 | <0.001 | ||
Eastern China | 37.6 | |||
Middle China | 37.7 | |||
Western China | 24.7 | |||
Current smoker | 1773.413 | <0.001 | ||
Yes | 24 | |||
No | 76 | |||
Alcohol use | 1162.729 | <0.001 | ||
Yes | 29 | |||
No | 71 | |||
BMI Group | 3451.943 | <0.001 | ||
Underweight | 2.60 | |||
Normal weight | 35.82 | |||
Overweight or obese | 61.58 |
Risk Factors | Total | Men | Women | χ2 | p |
---|---|---|---|---|---|
Hypertension | 78.51 | 78.20 | 78.86 | 0.422 | 0.516 |
Dyslipidemia | 54.38 | 52.77 | 56.22 | 7.867 | 0.005 |
Diabetes | 21.75 | 20.49 | 23.2 | 0.062 | 0.008 |
Lack of exercise | 16.35 | 16.43 | 16.27 | 0.029 | 0.865 |
Atrial fibrillation | 4.47 | 4.26 | 4.7 | 0.749 | 0.387 |
Overweight or obese | 61.58 | 58.99 | 64.55 | 21.390 | <0.001 |
Smoking | 24.04 | 40.3 | 5.36 | 1094.201 | <0.001 |
Family history of stroke | 17.43 | 16.79 | 18.16 | 2.133 | 0.144 |
Four or more risk factors | 25.74 | 34.27 | 15.94 | 287.674 | <0.001 |
Awareness Rate | χ2 | p | Treatment Rate | χ2 | p | Control Rate | χ2 | p | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Men | Women | Total | Men | Women | Total | Men | Women | |||||||
Hypertension (n = 5166) | 73.62 | 72.2 | 75.23 | 6.062 | 0.014 | 70.19 | 68.35 | 72.29 | 9.523 | 0.002 | 17.79 | 17.77 | 17.81 | 0.002 | 0.967 |
Diabetes (n = 1431) | 69.74 | 66.99 | 72.54 | 5.212 | 0.022 | 65.83 | 62.55 | 69.15 | 6.933 | 0.009 | 34.59 | 32.32 | 36.9 | 3.324 | 0.068 |
Dyslipidemia (n = 3578) | 42.37 | 38.13 | 46.95 | 28.479 | <0.001 | 29.4 | 26.01 | 33.06 | 21.403 | <0.001 | 20.07 | 17.66 | 22.66 | 13.912 | 0.000 |
Sex | χ2 | p | |||
---|---|---|---|---|---|
Total | Men | Women | |||
Hypertension (n = 3626) | |||||
Take medicine as medically advised | 91.31 | 91.17 | 91.46 | 0.094 | 0.760 |
Diet control | 58.88 | 56.46 | 61.49 | 9.462 | 0.002 |
Increase exercise | 45.78 | 46.68 | 44.81 | 1.267 | 0.260 |
Blood pressure monitoring | 73.99 | 74.00 | 73.93 | 0.000 | 0.989 |
Diabetes (n = 942) | |||||
Oral medications | 78.24 | 77.16 | 79.23 | 0.588 | 0.443 |
Insulin injection | 34.71 | 38.36 | 31.36 | 5.075 | 0.024 |
Diet control | 85.77 | 83.15 | 88.19 | 4.892 | 0.027 |
Increase exercise | 57.86 | 60.53 | 55.4 | 2.542 | 0.111 |
Blood glucose monitoring | 78.24 | 80.49 | 76.17 | 2.573 | 0.109 |
Dyslipidemia (n = 1052) | |||||
Take medicine as medically advised | 80.61 | 79.92 | 81.20 | 0.273 | 0.601 |
Diet control | 77.57 | 76.19 | 78.73 | 0.972 | 0.324 |
Increase exercise | 56.46 | 54.87 | 57.82 | 0.928 | 0.335 |
Blood lipid monitoring | 40.3 | 36.65 | 43.41 | 4.967 | 0.026 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chen, J.; Zhu, Q.; Yu, L.; Li, Y.; Jia, S.; Zhang, J. Stroke Risk Factors of Stroke Patients in China: A Nationwide Community-Based Cross-Sectional Study. Int. J. Environ. Res. Public Health 2022, 19, 4807. https://doi.org/10.3390/ijerph19084807
Chen J, Zhu Q, Yu L, Li Y, Jia S, Zhang J. Stroke Risk Factors of Stroke Patients in China: A Nationwide Community-Based Cross-Sectional Study. International Journal of Environmental Research and Public Health. 2022; 19(8):4807. https://doi.org/10.3390/ijerph19084807
Chicago/Turabian StyleChen, Jingyi, Qianrang Zhu, Lianlong Yu, Yuqian Li, Shanshan Jia, and Jian Zhang. 2022. "Stroke Risk Factors of Stroke Patients in China: A Nationwide Community-Based Cross-Sectional Study" International Journal of Environmental Research and Public Health 19, no. 8: 4807. https://doi.org/10.3390/ijerph19084807
APA StyleChen, J., Zhu, Q., Yu, L., Li, Y., Jia, S., & Zhang, J. (2022). Stroke Risk Factors of Stroke Patients in China: A Nationwide Community-Based Cross-Sectional Study. International Journal of Environmental Research and Public Health, 19(8), 4807. https://doi.org/10.3390/ijerph19084807